Methamphetamine use in Melbourne, Australia: Baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence

Journal of Substance Use

Volumn 18, Issue 5, 2013, Pages 349-362

  Quinn, Brendan ^a,b   Stoové, Mark ^a   Papanastasiou, Cerissa ^a   Dietze, Paul ^a  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Dependence; Melbourne; Methamphetamine; Polysubstance use

Indexed keywords

CANNABIS; DIAMORPHINE; METHAMPHETAMINE;

ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; COHORT ANALYSIS; CORRELATIONAL STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRUCTURED QUESTIONNAIRE;

EID: 84882983094     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.3109/14659891.2012.675400     Document Type: Article

References (55)

1. Aitken, C., Brough, R., & Crofts, N. (1999). Injecting drug use and blood-borne viruses: A comparison of rural and urban Victoria, 1990-95. Drug and Alcohol Review, 18, 47-52.
2. Australian Bureau of Statistics. (2001). Information paper: Use of the Kessler Psychological Distress Scale in ABS health surveys, Australia. Canberra: Author.
3. Australian Crime Commission. (2010). Illicit drug data report: 2008-09. Canberra: Author.
4. Australian Crime Commission. (2011). Illicit drug data report: 2009-10. Canberra: Author.
5. Australian Institute of Health and Welfare. (2010). Alcohol and other drug treatment services in Australia 2008-09: Report on the National Minimum Data Set. Canberra: Author.
6. Australian Institute of Health and Welfare. (2011). 2010 National drug strategy household survey report. Canberra: Author.
7. Baker, A., Boggs, T. G., & Lewin, T. J. (2001a). Characteristics of regular amphetamine users and implications for treatment. Drug and Alcohol Review, 20, 49-56.
8. Baker, A., Boggs, T. G., & Lewin, T. J. (2001b). Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine. Addiction, 96, 1279-1287.
9. Baker, A., & Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist, 40(2), 88-95.
10. Brecht, M. L., O'Brien, A., von Mayrhauser, C., & Anglin, M. D. (2004). Methamphetamine use behaviors and gender differences. Addictive Behaviors, 29(1), 89-106.
11. Bush, K., Kivlahan, D. R., McDonnell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Archives of Internal Medicine, 158, 1789-1795.
12. Christian, D. R., Huber, A., Brecht,M. L., McCann,M. J., Marinelli-Casey, P., Lord, R. H., Reiber, C., Lu, T. H., The Methamphetamine Treatment Project, & Galloway, G. P. (2007). Methamphetamine users entering treatment: Characteristics of the methamphetamine treatment project sample. Substance Use&Misuse, 42, 2207-2222.
13. Cogger, S., McKetin, R., Ross, J., & Najman, J. (2008). Methamphetamine Treatment Evaluation Study (MATES): Findings from the Brisbane site. Sydney: National Drug and Alcohol Research Centre.
14. Darke, S., & Hall, W. (1995). Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug and Alcohol Dependence, 89, 1683-1690.
15. Darke, S., Hall, W.,Wodak, A., Heather, N., &Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction, 87, 733-742.
16. Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 253-262.
17. Deady, M. (2009). A Review of screening, assessment and outcome measures for drug and alcohol settings. Strawberry Hills: Network of Alcohol & other Drug Agencies (NADA).
18. Degenhardt, L., Baker, A., &Maher, L. (2008a). Methamphetamine: Geographic areas and populations at risk, and emerging evidence for effective interventions (editorial). Drug and Alcohol Review, 27(3), 217-219.
19. Degenhardt, L., Mathers, B., Guarinieri, M., Panda, S., Phillips, B., Strathdee, S. A., Tyndall, M., Wiessing, L., &Wodak, A. (2007). The global epidemiology ofmethamphetamine injection:Areview of the evidence on use and associations with HIV and other harm. Sydney: National Drug and Alcohol Research Centre, University of New SouthWales.
20. Degenhardt, L., Roxburgh, A., Black, E., Bruno, R., Campbell, G., Kinner, S., & Fetherston, J. (2008b). The epidemiology of methamphetamine use and harm in Australia. [Research Support, Non-U.S. Gov't Review]. Drug and Alcohol Review, 27(3), 243-252.
21. Feigin, A., Dietze, P., & Lloyd, B. (2011). Victorian trends in ecstasy and related drug markets 2010: Findings from the Ecstasy and related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
22. Fry, C. L., Hall, W., Ritter, A., & Jenkinson, R. (2006). The ethics of paying drug users who participate in research: A review and practical recommendations. Journal of Empirical Research on Human Research Ethics, 1(4), 21-36.
23. Gaffney, A., Jones, W., Sweeney, J., & Payne, J. (2010). Drug use monitoring in Australia: 2008 annual report on drug use among police detainees. Canberra: Australian Institute of Criminology.
24. Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction, 90, 607-614.
25. Greenwell, L., & Brecht, M. (2003). Self-reported health status among treated methamphetamine users. American Journal of Drug and Alcohol Abuse, 29(1), 75-104.
26. Hando, J., Topp, L., & Hall, W. (1997). Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence, 46, 105-113.
27. Hayatbakhsh, M. R., Najman, J. M., Bor, W., & Williams, G. M. (2009). Predictors of young adults' amphetamine use and disorders: A prospective study. [Research Support, Non-U.S. Gov't]. Drug and Alcohol Review, 28(3), 275-283.
28. Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174-199.
29. Johnston, J., Laslett, A.-M., Miller, P., Jenkinson, R., Fry, C., & Dietze, P. (2004). Victorian psychostimulant monitoring project: Trialling enhanced drug trend monitoring of Melbourne psychostimulant markets (final report). Fitzroy: Turning Point Alcohol and Drug Centre.
30. Kelly, E., McKetin, R., &McLaren, J. (2005). Health service utilisation among regular methamphetamine users. Sydney: NDARC.
31. Kenny, P., Harney, A., Lee, N. K., & Pennay, A. (2011). Treatment utilization and barriers to treatment: Results of a survey of dependent methamphetamine users. Substance Abuse, Treatment, Prevention, and Policy, 6(3), 1-7.
32. Kessler, R. C. (1996). Kessler Psychological Distress Scale (K10). Boston, MA: Harvard Medical School.
33. Klee, H., & Morris, J. (1994). Factors that lead young amphetamine misusers to seek help: Implications for drug prevention and harm reduction. Drugs: Education, Prevention and Policy, 1(3), 289-297.
34. Klee, H., Wright, S., & Morris, J. (1999). Amphetamine users in treatment: Factors associated with sustained abstinence from street drugs. Addiction Research, 7(3), 239-265.
35. Macgregor, S., & Payne, J. (2011). Findings from the DUMA program: Increase in use of methamphetamine. Canberra: Australian Institute of Criminology.
36. McKetin, R., & Kelly, E. (2007). Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug and Alcohol Review, 26, 161-168.
37. McKetin, R., Kelly, E., & McLaren, J. (2006a). The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence, 85, 198-204.
38. McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006b). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101(10), 1473-1478.
39. McKetin, R., Kelly, E., McLaren, J., & Proudfoot, H. (2008a). Impaired physical health among methamphetamine users in comparison with the general population: The role of methamphetamine dependence and opioid use. Drug and Alcohol Review, 27(5), 482-489.
40. McKetin, R., Ross, J., Kelly, E., Baker, A., Lee, N., Lubman, D. I.,&Mattick, R. (2008b). Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug and Alcohol Review, 27(3), 277-285.
41. McKetin, R., McLaren, J., & Kelly, E. (2005a). The dynamics of the Sydney methamphetamine market: An overview of supply, use patterns, harms and social consequences. Adelaide: Australasian Centre for Policing Research.
42. McKetin, R., McLaren, J., & Kelly, E. (2005b). The Sydney methamphetamine market: Patterns of supply, use, personal harms and social consequences. Sydney: National Drug and Alcohol Research Centre, University of NSW.
43. McKetin, R., McLaren, J., Kelly, E., Hall, W., & Hickman, M. (2005c). Estimating the number of regular and dependent methamphetamine users in Australia. Sydney: NDARC, UNSW.
44. McKetin, R., Sutherland, R., Ross, J., Najman, J., Mamun, A., Baker, A., Mattick, R., & Rosenfield, J. (2010). Methamphetamine Treatment Evaluation Study (MATES): Three-year outcomes from the Sydney site. Sydney: NDARC, UNSW.
45. Reddel, S. E., Horyniak, D., Dietze, P., & McElwee, P. (2011). Victorian Drug Trends 2010: Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
46. Ross, J., &Miller, S. (1994). Hidden use of amphetamine in metropolitan Melbourne. In R. Godding & G. Whelan (Eds.), Proceedings of the 1994 autumn school of studies on alcohol and drugs (pp. 49-52). Melbourne: Department of Drug and Alcohol Studies, St Vincent's Hospital.
47. Sindicich, N., & Burns, L. (2011). Australian trends in ecstasy and related drug markets 2010: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
48. Stafford, J., & Burns, L. (2011). Australian drug trends 2010: Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
49. Topp, L., &Mattick, R. P. (1997). Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction, 92, 839-845.
50. United Nations Office on Drugs and Crime. (2011). Amphetamines and ecstasy: 2011 global ATS assessment. Vienna: Author.
51. Victorian Government Department of Health. (2011). The Victorian drug statistics handbook: Patterns of drug use and related harm in Victoria for the period July 2008 to June 2009. Melbourne: Author.
52. Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1999). Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review, 18, 63-73.
53. Wallace, C., Galloway, T., McKetin, R., Kelly, E., & Leary, J. (2009). Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug and Alcohol Review, 28, 592-599.
54. Wright, S., & Klee, H. (1999). A profile of amphetamine users who present to treatment services and do not return. Drugs: Education, Prevention and Policy, 6(2), 227-241.
55. Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., & Iguchi, M. (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13(2), 181-190.